Neurocrine Biosciences shares owned by China Universal Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by China Universal Asset Management
from 13F filings
Historical chart of China Universal Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by China Universal Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.4M | 17k | 140.38 |
| 2025-06-30 | $2.5M | 20k | 125.69 |
| 2025-03-31 | $2.2M | 20k | 110.60 |
| 2024-12-31 | $2.9M | 22k | 136.50 |
| 2024-09-30 | $2.2M | 19k | 115.22 |
| 2024-06-30 | $1.6M | 12k | 137.67 |
| 2024-03-31 | $2.6M | 19k | 137.92 |
| 2023-12-31 | $1.5M | 11k | 131.76 |
| 2023-09-30 | $282k | 2.5k | 112.62 |
| 2023-06-30 | $121k | 1.3k | 94.61 |
| 2023-03-31 | $132k | 1.3k | 100.84 |
| 2022-12-31 | $117k | 977 | 119.75 |
| 2022-09-30 | $95k | 896 | 106.03 |
More positions owned by China Universal Asset Management
View all positions for China Universal Asset Management